{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:10:22Z","timestamp":1773421822017,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T00:00:00Z","timestamp":1324598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00125-011-2417-9","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T17:53:51Z","timestamp":1324576431000},"page":"795-800","source":"Crossref","is-referenced-by-count":28,"title":["Small fibre dysfunction, microvascular complications and glycaemic control in type 1 diabetes: a case\u2013control study"],"prefix":"10.1007","volume":"55","author":[{"given":"P. R. J.","family":"Vas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Q.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rayman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,23]]},"reference":[{"issue":"1","key":"2417_CR1","first-page":"30","volume":"6","author":"ASP Gordois","year":"2003","unstructured":"Gordois ASP, Shearer A, Oglesby A (2003) The costs and consequences of peripheral neuropathy in the UK. Diabet Foot 6(1):30\u201337","journal-title":"Diabet Foot"},{"key":"2417_CR2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00125-004-1663-5","volume":"48","author":"RA Malik","year":"2005","unstructured":"Malik RA, Tesfaye S, Newrick PG et al (2005) Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48:578\u2013585","journal-title":"Diabetologia"},{"key":"2417_CR3","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.2337\/diacare.27.12.2930","volume":"27","author":"ST Krishnan","year":"2004","unstructured":"Krishnan ST, Rayman G (2004) The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care 27:2930\u20132935","journal-title":"Diabetes Care"},{"key":"2417_CR4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/brain\/awh180","volume":"127","author":"CT Shun","year":"2004","unstructured":"Shun CT, Chang YC, Wu HP et al (2004) Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 127:1593\u20131605","journal-title":"Brain"},{"key":"2417_CR5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/cs0800605","volume":"80","author":"D Walmsley","year":"1991","unstructured":"Walmsley D, Wiles PG (1991) Early loss of neurogenic inflammation in the human diabetic foot. Clin Sci (Lond) 80:605\u2013610","journal-title":"Clin Sci (Lond)"},{"key":"2417_CR6","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/WNL.57.9.1701","volume":"57","author":"AG Smith","year":"2001","unstructured":"Smith AG, Ramachandran P, Tripp S, Singleton JR (2001) Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 57:1701\u20131704","journal-title":"Neurology"},{"key":"2417_CR7","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/diacare.24.8.1448","volume":"24","author":"JR Singleton","year":"2001","unstructured":"Singleton JR, Smith AG, Bromberg MB (2001) Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24:1448\u20131453","journal-title":"Diabetes Care"},{"key":"2417_CR8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/mus.1137","volume":"24","author":"SP Novella","year":"2001","unstructured":"Novella SP, Inzucchi SE, Goldstein JM (2001) The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 24:1229\u20131231","journal-title":"Muscle Nerve"},{"key":"2417_CR9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2337\/dc09-0101","volume":"33","author":"AQ Green","year":"2010","unstructured":"Green AQ, Krishnan S, Finucane FM, Rayman G (2010) Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance. Diabetes Care 33:174\u2013176","journal-title":"Diabetes Care"},{"key":"2417_CR10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2337\/dc08-1453","volume":"32","author":"ST Krishnan","year":"2009","unstructured":"Krishnan ST, Quattrini C, Jeziorska M, Malik RA, Rayman G (2009) Abnormal LDIflare but normal quantitative sensory testing and dermal nerve fiber density in patients with painful diabetic neuropathy. Diabetes Care 32:451\u2013455","journal-title":"Diabetes Care"},{"key":"2417_CR11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/mus.21333","volume":"40","author":"AQ Green","year":"2009","unstructured":"Green AQ, Krishnan ST, Rayman G (2009) C-fiber function assessed by the laser doppler imager flare technique and acetylcholine iontophoresis. Muscle Nerve 40:985\u2013991","journal-title":"Muscle Nerve"},{"key":"2417_CR12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1464-5491.2002.00698.x","volume":"19","author":"CA Abbott","year":"2002","unstructured":"Abbott CA, Carrington AL, Ashe H et al (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19:377\u2013384","journal-title":"Diabet Med"},{"key":"2417_CR13","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.2337\/diacare.25.11.2048","volume":"25","author":"V Bril","year":"2002","unstructured":"Bril V, Perkins BA (2002) Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 25:2048\u20132052","journal-title":"Diabetes Care"},{"key":"2417_CR14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome\u2014a new worldwide definition. Lancet 366:1059\u20131062","journal-title":"Lancet"},{"issue":"supplement 1","key":"2417_CR15","first-page":"65","volume":"28","author":"P Vas","year":"2011","unstructured":"Vas P, Rayman G (2011) The modified laser Doppler imagery flare: a simple and quick method to assess C fibre function in the diabetes clinic. Diabet Med 28(supplement 1):65 (abstract)","journal-title":"Diabet Med"},{"key":"2417_CR16","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s001250050586","volume":"39","author":"S Tesfaye","year":"1996","unstructured":"Tesfaye S, Stevens LK, Stephenson JM et al (1996) Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39:1377\u20131384","journal-title":"Diabetologia"},{"key":"2417_CR17","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.2337\/dc09-0554","volume":"32","author":"J Elliott","year":"2009","unstructured":"Elliott J, Tesfaye S, Chaturvedi N et al (2009) Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors. Diabetes Care 32:1896\u20131900","journal-title":"Diabetes Care"},{"key":"2417_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1529-8027.2010.00271.x","volume":"15","author":"G Lauria","year":"2010","unstructured":"Lauria G, Bakkers M, Schmitz C et al (2010) Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 15:202\u2013207","journal-title":"J Peripher Nerv Syst"},{"key":"2417_CR19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","volume":"123","author":"R Rolke","year":"2006","unstructured":"Rolke R, Baron R, Maier C et al (2006) Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123:231\u2013243","journal-title":"Pain"},{"key":"2417_CR20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/mus.20053","volume":"29","author":"PST Chong","year":"2004","unstructured":"Chong PST, Cros DP (2004) Technology literature review: quantitative sensory testing. Muscle Nerve 29:734\u2013747","journal-title":"Muscle Nerve"},{"key":"2417_CR21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/mus.20732","volume":"35","author":"T Umapathi","year":"2007","unstructured":"Umapathi T, Tan WL, Loke SC, Soon PC, Tavintharan S, Chan YH (2007) Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve 35:591\u2013598","journal-title":"Muscle Nerve"},{"key":"2417_CR22","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye S, Boulton AJ, Dyck PJ et al (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285\u20132293","journal-title":"Diabetes Care"},{"key":"2417_CR23","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2337\/db08-1771","volume":"58","author":"TD Wiggin","year":"2009","unstructured":"Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL (2009) Elevated triacylglycerols correlate with progression of diabetic neuropathy. Diabetes 58:1634\u20131640","journal-title":"Diabetes"},{"key":"2417_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2008.06.005","volume":"273","author":"AG Smith","year":"2008","unstructured":"Smith AG, Rose K, Singleton JR (2008) Idiopathic neuropathy patients are at high risk for metabolic syndrome. J Neurol Sci 273:25\u201328","journal-title":"J Neurol Sci"},{"key":"2417_CR25","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2337\/dc10-0456","volume":"33","author":"M Charles","year":"2010","unstructured":"Charles M, Soedamah-Muthu SS, Tesfaye S et al (2010) Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 33:2648\u20132653","journal-title":"Diabetes Care"},{"key":"2417_CR26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/157339906776818569","volume":"2","author":"KA Kles","year":"2006","unstructured":"Kles KA, Vinik AI (2006) Pathophysiology and treatment of diabetic peripheral neuropathy: the case for diabetic neurovascular function as an essential component. Curr Diabetes Rev 2:131\u2013145","journal-title":"Curr Diabetes Rev"},{"key":"2417_CR27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF00505180","volume":"32","author":"RA Malik","year":"1989","unstructured":"Malik RA, Newrick PG, Sharma AK et al (1989) Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 32:92\u2013102","journal-title":"Diabetologia"},{"key":"2417_CR28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1464-5491.1991.tb01530.x","volume":"8","author":"A Veves","year":"1991","unstructured":"Veves A, Malik RA, Lye RH et al (1991) The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabet Med 8:917\u2013921","journal-title":"Diabet Med"},{"key":"2417_CR29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","volume":"33","author":"JW Albers","year":"2010","unstructured":"Albers JW, Herman WH, Pop-Busui R et al (2010) Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care 33:1090\u20131096","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2417-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-011-2417-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2417-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:49:36Z","timestamp":1558612176000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-011-2417-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,23]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["2417"],"URL":"https:\/\/doi.org\/10.1007\/s00125-011-2417-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,23]]}}}